Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. Based in the United States, this Deer Park, Illinois..
AxoGen, Inc. (AXGN), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive potential upside of 47.85%. As a leader in peripheral..
Investors eyeing the cannabis industry often find themselves considering Cronos Group Inc. (NASDAQ: CRON), a key player in the cannabinoid space with a growing international footprint. With a market capitalization..
InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has been making waves with its innovative aesthetic medical products. Headquartered in Yokne’am,..
Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, specifically within the drug manufacturers’ specialty and generic segment, is making waves in the aesthetic market. With its flagship..
Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with its promising pipeline focused on addressing infectious diseases, particularly chronic Hepatitis B virus (HBV). As a clinical-stage..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, stands at the forefront of developing transformative cell and exosome-based therapeutics. With a focus on addressing unmet medical needs, the company..
Valneva SE (NASDAQ: VALN), a French biotechnology company, is gaining attention for its promising pipeline of vaccines targeting infectious diseases with unmet medical needs. With a market cap of $889.79..
Embecta Corp. (EMBC), a stalwart in the healthcare sector, is carving out its niche within the medical instruments and supplies industry. Headquartered in Parsippany, New Jersey, this company has a..
Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing investor attention with its significant potential upside of 115.63%, as indicated by recent analyst ratings. This clinical-stage biotechnology company is strategically positioned within..
Pharvaris N.V. (PHVS), a biopharmaceutical company headquartered in Zug, Switzerland, is making waves in the healthcare sector with its innovative approach to tackling rare diseases. Specializing in the development of..
Auna SA (AUNA), a Luxembourg-based healthcare provider with operations extending across Mexico, Peru, and Colombia, is capturing the attention of investors with its promising potential upside of 89.10%. As a..
Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its impressive potential upside of 87.01%. With an average target price of $9.50, significantly higher than its..
LENZ Therapeutics, Inc. (NASDAQ: LENZ), a promising player in the biotechnology sector, is drawing significant investor interest with its focus on vision-improving therapies. As a biopharmaceutical company, LENZ is currently..
Investors in the healthcare sector may want to keep an eye on Weave Communications, Inc. (NASDAQ: WEAV), a company that has carved out a niche in providing customer experience and..
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, is catching the attention of investors with its promising focus on T cell redirecting immunotherapies for cancer treatment...
Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector specializing in medical devices, is captivating investor attention with its significant potential upside of nearly 96.87%. Based in..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector, particularly in the realm of specialty pharmaceuticals focused on pain management. With a market capitalization of $1.05 billion, this..
Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, finds itself navigating a complex landscape as it seeks to leverage its extensive experience in medical distribution. With..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its compelling growth story within the healthcare sector. This commercial-stage biopharmaceutical company, specializing in therapies for chronic..
